ストックスクリーナーアプリを入手
0.7748
5.06%
0.0373
前日終値:
$0.7375
開ける：
$0.7599
24時間の取引高:
23,250
Relative Volume:
0.25
時価総額：
$3.36M
収益：
$79,300
当期純損益:
$-6.92M
株価収益率:
-0.0408
EPS:
-18.9818
ネットキャッシュフロー:
$-5.34M
1週間 パフォーマンス:
-1.16%
1か月 パフォーマンス:
-10.94%
6か月 パフォーマンス:
-59.31%
1年 パフォーマンス:
-44.26%
1日の値動き範囲:
$0.7401
$0.795
1週間の範囲:
$0.7222
$0.7999
52週間の値動き範囲:
$0.7222
$8.9999
Virax Biolabs Group Ltd Stock (VRAX) Company Profile
VRAX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
VRAX
Virax Biolabs Group Ltd
|
0.7748 | 3.20M | 79,300 | -6.92M | -5.34M | -18.98 |
|
VRTX
Vertex Pharmaceuticals Inc
|
392.79 | 100.07B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.41 | 59.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
448.91 | 58.03B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
653.83 | 39.93B | 3.06B | 1.28B | -614.78M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
321.36 | 36.82B | 3.81B | -644.79M | -669.77M | -6.24 |
Virax Biolabs Group Ltd Stock (VRAX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-03-31 | 開始されました | H.C. Wainwright | Buy |
Virax Biolabs Group Ltd (VRAX) 最新ニュース
How to manage a losing position in Virax Biolabs Group LimitedJuly 2025 Trade Ideas & Daily Risk Controlled Trade Plans - Newser
Is Virax Biolabs Group Limited stock entering bullish territoryQuarterly Portfolio Review & High Conviction Trade Alerts - Newser
Smart tools for monitoring Virax Biolabs Group Limited’s price action2025 Macro Impact & Fast Entry Momentum Alerts - Newser
Analyzing drawdowns of Virax Biolabs Group Limited with statistical tools2025 AllTime Highs & Accurate Entry/Exit Alerts - Newser
Virax Biolabs Group Limited Attempts Reversal From Key Support2025 Fundamental Recap & Long-Term Growth Plans - beatles.ru
Market reaction to Virax Biolabs Group Limited’s recent newsStop Loss & Short-Term High Return Strategies - Newser
Is Virax Biolabs Group Limited stock reversal real or fakeFree Entry Alert Based on Volume Spikes - Newser
Applying big data sentiment scoring on Virax Biolabs Group LimitedFree Trend Following Strategy With Stop Loss - Newser
Virax Biolabs Group Limited stock trend forecastPrice Spike Prediction for Active Traders - Newser
Can momentum traders help lift Virax Biolabs Group LimitedTrade Safety Report with Pattern Insights - Newser
Using AI based signals to follow Virax Biolabs Group LimitedRapid Trade Forecast Based on Indicators - Newser
What makes Virax Biolabs Group Limited stock price move sharplyFree Secure Return Focused Investment Plan - Newser
Visualizing Virax Biolabs Group Limited stock with heatmapsFree Real Time Stock Movement Analysis - Newser
Does Virax Biolabs Group Limited stock perform well during market downturnsDiscover high-growth stocks for your portfolio - Jammu Links News
How does Virax Biolabs Group Limited generate profit in a changing economyCapitalize on emerging industry trends - Jammu Links News
What catalysts could drive Virax Biolabs Group Limited stock higher in 2025Achieve consistent profits with proven methods - Jammu Links News
Is it the right time to buy Virax Biolabs Group Limited stockBuild a diversified portfolio for steady growth - Jammu Links News
Virax Biolabs Appoints Dr. Iain Miller as New Independent Director - TipRanks
Published on: 2025-07-30 13:38:22 - beatles.ru
How to build a custom watchlist for Virax Biolabs Group LimitedHigh Yield Signals with Entry Timing - Newser
Virax Biolabs Group Limited’s volatility index tracking explainedFree Risk Controlled Picks With Real Returns - Newser
Virax Biolabs appoints Iain Miller as independent director - Investing.com Australia
Former GE Healthcare Executive Joins Virax Board to Accelerate Diagnostic Platform Expansion - Stock Titan
Using economic indicators to assess Virax Biolabs Group Limited potentialFree Real Profit Trade Plan Suggestions - Newser
Virax Biolabs Appoints Iain Miller, PhD as Independent Director to Accelerate Commercial Strategy - Yahoo Finance
Is Virax Biolabs Group Limited stock overvalued or undervaluedFree Daily Trading Room Entry - jammulinksnews.com
What are the latest earnings results for Virax Biolabs Group LimitedBuild wealth with steady, reliable stocks - Jammu Links News
Why is Virax Biolabs Group Limited stock attracting strong analyst attentionGet real-time alerts on top stocks - Jammu Links News
Technical Analysis: TGB Banquets and Hotels Limited (532845)Consistent wealth multiplication - Autocar Professional
Virax Biolabs Group Limited Stock Analysis and ForecastFree Wealth Planning Blueprint - jammulinksnews.com
Technical Analysis: SPEL Semiconductor Limited (517166)Extraordinary performance - Autocar Professional
Is Virax Biolabs Group Limited a good long term investmentSuperior trading gains - jammulinksnews.com
What analysts say about Allient Inc. stockGame-changing returns - jammulinksnews.com
What analysts say about Virax Biolabs Group Limited stockExceptional market performance - Jammu Links News
AI for Trademark Infringement DetectionAlpha Stock Ideas - Newser
ICICI Prudential AMC Ltd (542631) Announces Strategic ShiftExceptional earning trajectories - jammulinksnews.com
What drives Virax Biolabs Group Limited stock priceAccelerated wealth building - Autocar Professional
Virax Biolabs receives Nasdaq minimum bid price deficiency notice By Investing.com - Investing.com India
Virax Biolabs receives Nasdaq minimum bid price deficiency notice - Investing.com Australia
Virax Biolabs Gets NASDAQ Deficiency Notice: What the 180-Day Compliance Timeline Means for Investors - Stock Titan
How Virax Biolabs Group Limited stock performs during market volatilityFree Step-by-Step Investment Guide - Newser
Why ATCH stock attracts strong analyst attentionFree Consultation - Newser
Why Virax Biolabs Group Limited stock attracts strong analyst attentionFree Stock Portfolio Optimization - Newser
Virax Biolabs Group (NASDAQ:VRAX) Stock Price Up 0.7% – Time to Buy? - Defense World
Virax Biolabs Group Full Year 2025 Earnings: Misses Expectations - simplywall.st
Virax Biolabs Announces CFO Resignation and Transition - TipRanks
FibroBiologics names new CFO after going public last year - The Business Journals
Virax Biolabs Group Ltd (VRAX) 財務データ
収益
当期純利益
現金流量
EPS
0.41%
0.88%
大文字化:
|
ボリューム (24 時間):